🔎 Trials Near Me

Akèy › Limfom Difize Gwo Selil B › Virginia › Charlottesville

Etid klinik pou Limfom Difize Gwo Selil B nan Charlottesville, VA

7 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote Charlottesville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Ap rekriteFaz 2
  • University of Virginia, Charlottesville
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06500273

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Ap rekriteFaz 2
  • University of Virginia Cancer Center, Charlottesville
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06649812

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Ap rekriteFaz 1/2
  • University of Virginia Health System, Charlottesville
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Ap rekriteFaz 2
  • University of Virginia Health System, Charlottesville
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05852717

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Ap rekriteFaz 1
  • University of Virginia Cancer Center, Charlottesville
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT06015880

A Study of NX-1607 in Adults With Advanced Malignancies

Ap rekriteFaz 1
  • University of Virginia, Charlottesville
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Etid Limfom Difize Gwo Selil B nan lòt vil

Lòt etid nan Charlottesville

Sous ClinicalTrials.gov, done yo ranmase Oct 4, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.